Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study.
Gary TseSharen LeeTong LiuJiandong ZhouPublished in: Cardiovascular drugs and therapy (2024)